Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+134.6%
5Y CAGR+31.9%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+134.6%/yr
Annual compound
5Y CAGR
+31.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $901.10M | +35.8% |
| 2024 | $663.64M | +96.3% |
| 2023 | $338.08M | +384.5% |
| 2022 | $69.79M | +13.7% |
| 2021 | $61.36M | -72.8% |
| 2020 | $225.60M | +37986.7% |
| 2019 | $-595449.00 | +99.5% |
| 2018 | $-127.92M | -152.0% |
| 2017 | $-50.77M | - |
| 2016 | $0.00 | - |